Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Mihály MEDVEGY"'
Publikováno v:
Studia Universitatis Babeş-Bolyai: Educatio Artis Gymnasticae, Vol 67, Iss 3 (2022)
Previous studies show that physical sports strengthen the psychological immunity, namely the resilience. In our research, we sought to answer the question of whether the above statement was also true for chess, one of the most popular mind sports. Th
Externí odkaz:
https://doaj.org/article/ba572df2518a4fd4b91b45aee8dbb30a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mihály Medvegy, Gábor Simonyi
Publikováno v:
Cardiology and Therapy
Myocardial damage with a consequent rise in cardio-specific troponin level is a frequent phenomenon in severe cases of coronavirus disease 2019 (COVID-19). Its causes are capillary endothelial cell dysfunction, associated carditis, low oxygenization,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04dd60d2263cfcc0a0e8ae578906d328
http://europepmc.org/articles/PMC8018688
http://europepmc.org/articles/PMC8018688
Publikováno v:
Orvosi Hetilap. 161:839-845
Absztrakt: Bevezetés: A nonvalvularis pitvarfibrilláció (PF) orális antikoagulánssal (OAK) történő kezelésekor a terápiahűség igen jelentős tényező a stroke-prevencióban. Célkitűzés: OAK-terápiában részesülő, PF-ban szenvedő
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10067c9f8f584d05249aa5eb4d6fcf0
https://doi.org/10.1556/650.2020.31727
https://doi.org/10.1556/650.2020.31727
Publikováno v:
Orvosi Hetilap. 160:509-515
Abstract: Introduction: In the treatment of non-valvular atrial fibrillation (AF) with oral anticoagulants (OAC), medical adherence is a relevant factor for stroke prevention. Aim: To evaluate the one-year persistence of vitamin K antagonists (VKA) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d12f6bd3a06d0fe1ed75ea6692f51bc2
https://doi.org/10.1556/650.2019.31347
https://doi.org/10.1556/650.2019.31347
Autor:
Sándor Balogh, Iván Igaz, Gábor Simonyi, Roland Gasparics, Mihály Medvegy, Ervin Finta, Tamás Ferenci
Publikováno v:
Orvosi Hetilap. 160:343-348
Abstract: Introduction: The most recent European guidelines for the treatment of hypertension suggest the use of renin-angiotensin-aldosterone system antagonists (RAAS inhibitors) and calcium channel blockers (CCBs) or diuretics fixed-dose combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c0b88598c8eaa9595458c006a08dbe
https://doi.org/10.1556/650.2019.31355
https://doi.org/10.1556/650.2019.31355
Publikováno v:
Orvosi hetilap. 161(20)
Introduction: In the treatment of non-valvular atrial fibrillation (AF) with oral anticoagulant (OAC), the patients' adherence to therapy is a very important factor in stroke prevention. Aim: To investigate the one-year persistence of different OAC t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f32cbca66ce93e45622ccb2f65f0c86
https://pubmed.ncbi.nlm.nih.gov/32364687
https://pubmed.ncbi.nlm.nih.gov/32364687
Publikováno v:
Orvosi Hetilap. 158:1421-1425
Abstract: Introduction: In management of hypertension patient adherence is one of the most important factors. In hypertension the cardiovascular risk reduction can be reached only by prolonged and effective pharmacotherapy. Aim: To evaluate the persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff1fe14def2e613b4f8d35f4fe5ade38
https://doi.org/10.1556/650.2017.30851
https://doi.org/10.1556/650.2017.30851
Publikováno v:
European Heart Journal. 40
Introduction The latest ESC/ESH guidelines recommended fixed dose combinations (FDC) for first therapy in hypertension. Preferred two-drug combinations are a RAS (renin–angiotensin system) blocker with a CCBs (calcium channel blockers) or a diureti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e984e4a866b8593382989dc4125c1c90
https://doi.org/10.1093/eurheartj/ehz745.0952
https://doi.org/10.1093/eurheartj/ehz745.0952
Publikováno v:
Orvosi hetilap. 160(13)
In the treatment of non-valvular atrial fibrillation (AF) with oral anticoagulants (OAC), medical adherence is a relevant factor for stroke prevention.To evaluate the one-year persistence of vitamin K antagonists (VKA) and direct oral anticoagulants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6416bbac40d0583b5524a19c4f85985
https://pubmed.ncbi.nlm.nih.gov/30907102
https://pubmed.ncbi.nlm.nih.gov/30907102